Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia	University of California San Francisco / Elliot Stieglitz, MD	Young Investigator Grants	2015	California
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer Directed Therapy	Dana-Farber Cancer Institute / Andrew Hong, MD	Young Investigator Grants	2015	Massachusetts
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor	Dana-Farber Cancer Institute / Shuning He, PhD	Young Investigator Grants	2015	Massachusetts
Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas	University of California, Davis Medical Center / Paul Knoepfler, PhD	Innovation Grants	2015	California
Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering	Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD	Innovation Grants	2015	New York
Integrative Genomic and Immunogenomic Analysis of Neuroblastoma	University of California at Santa Cruz / David Haussler, PhD	Innovation Grants	2015	California
Functional Analysis and Therapeutic Targeting of STAG2 Mutations in Ewing sarcoma	Georgetown University / Todd Waldman, MD, PhD	Innovation Grants	2015	District of Columbia
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina / Timothy Gershon, MD, PhD	Innovation Grants	2015	North Carolina
Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia	Boston Children’s Hospital / Alan Cantor, MD, PhD	Innovation Grants	2015	Massachusetts
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma	University of Virginia, School of Medicine / John Bushweller, PhD	Innovation Grants	2015	Virginia

Pages